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Copyright © 200? JCBN Summary The present study was undertaken to evaluate the effects of lansoprazole (LPZ) on
lipopolysaccharide (LPS)-stimulated toll-like receptor 4 (TLR4) signal transduction systems
using the 293hTLR4/MD2-CD14 cells. The cells were incubated and then divided into the
following groups: (a) untreated group, (b) non-LPZ treated (1h) group, (c) LPZ-treated (1h)
plus non LPS-stimulated (1h) group, (d) LPZ-treated (1h) plus non LPS-stimulated (6h) group,
(e) LPZ-treated (1h) plus LPS-stimulated (1h) group, (f) LPZ-treated (1h) plus LPS-stimulated
(6h) group, (g) non LPZ-treated (1h) plus LPS-stimulated (1h) group and (h) non LPZ-treated
(1h) plus LPS-stimulated (6h) group. Samples from each group were subjected to western
blotting for analysis of IkB phosphorylation, intranuclear transfer of NF-kB, phosphorylation
of MAP kinase (MAPK), intranuclear transfer of interferon regulatory factor 5 (IRF5), and
expression of suppressor of cytokine signaling-1 (SOCS1). In the LPZ-treated groups, neither
phosphorylation of MAPK nor intranuclear transfer of IRF5 was suppressed under stimula-
tion with LPS, and enhanced intranuclear transfer of NF-kB and increased expression of
SOCS1 were noted by comparison with the group treated with LPS alone. These results
suggest that LPZ stimulates the expression of SOCS1 and regulates protein phosphorylation
through its activity on TLR4 signal transduction under LPS stimulation.
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Introduction
Toll-like receptors (TLRs) have been identified as a
receptor of the innate immunity system which recognizes
exogenous microorganisms [1, 2]. Furthermore, analysis of
gene-knockout mice demonstrated that TLRs regulates not
only innate immunity, but also acquired immunity [3, 4]. It
has also been reported that excessive reactions of TLRs are
involved in various diseases [5, 6]. Toll-like receptor (TLR)
4 is a receptor capable of recognizing lipopolysaccharide
(LPS). TLR4 signal transduction system is regulated the
phosphorylation of IkB and NF-kB transfer into the nucleus,
the phosphorylation of MAP kinase, interferon regulatory
factor (IRF5) transfer into the nucleus. IRF5 transfer into the
nucleus is concerned with the production of cytokines and
regulates innate or acquired immunity no less than NF-kB
[7–9]. Suppressor of cytokine signaling-1 (SOCS1) has been
identified as a negative feed back gene involved in control of
excessive LPS stimulation [10–13]. SOCS1 regulates theT. Ohara et al.
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excess production of cytokines under stimulation with LPS.
Proton pump inhibitor (PPI), which suppresses acid output,
has been reported to additionally possess anti-inflammatory
and immune actions [14, 15]. The present study was under-
taken to evaluate the effects of PPI on TLR4 signal transduc-
tion (protein phosphorylation) in the 293hTLR4/MD2-
CD14 cells (transfected with TLR4, MD2 and CD14 genes
to yield human fibroblasts as HEK293 cells) under stimula-
tion with LPS.
Materials and Methods
In order to study under the condition of similar living
body, we used the 293hTLR4/MD2-CD14 cells in this study.
The 293hTLR4/MD2-CD14 cells is a transfected cells with
TLR4, MD2 and CD14 genes to yield HEK293 cell. We
purchased the 293hTLR4/MD2-CD14 cells from InvivoGen
(San Diego, CA). Lansoprazole (LPZ) as PPI was used. The
additional concentration of LPZ to the cells was prepared as
previously described [16]. The cells were incubated and
aliquots of 1.5 × 106 cells were plated on collagen-coated
6-well culture plates (Falcon, Heidelberg, Germany) and
cultured in 5% CO2-supplemented room atmosphere. The
viability of the 293hTLR4/MD2-CD14 cells was more than
95% as assessed by trypan blue exclusion. And then, the
cells divided into the following groups: (a) untreated group
(no culture), (b) non LPZ-treated (1h) group, (c) LPZ
(10−4 M)-treated (1h) plus non LPS-stimulated (1h) group,
(d) LPZ (10−4 M)-treated (1h) plus non LPS-stimulated
(6 hours: 6h) group, (e) LPZ (10−4 M)-treated (1h) plus LPS
(1 μg/ml)-stimulated (1h) group, (f) LPZ (10−4M)-treated
(1h) pus LPS (1 μg/ml)-stimulated (6h) group, (g) non LPZ-
treated (1h) plus LPS (1 μg/ml)-stimulated (1h) group and
(h) non LPZ-treated (1h) plus LPS (1 μg/ml)-stimulated (6h)
group. Extracts of samples from each group were subjected
to the following analyses.
Analysis of IkB phosphorylation and NF-kB transfer into
nucleus
Phosphorylation of IkB was analyzed by western blotting
using phospho-IkB-α (Ser32) antibody and IkB- antibody.
NF-kB transfer into the nucleus was analyzed by western
blotting of nuclear and cytoplasmic fractions using anti-NF-
kBp65 antibody. Phospho-IkB-α antibody, IkB-α antibody
and anti-NF-kBp65 antibody were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA).
Analysis of phosphorylation of MAP kinase (MAPK: ERK,
JNK and p38)
ERK was analyzed by western blotting using phospho-
p44/42 MAPK antibody and p44/42 MAPK antibody.
JNK was analyzed by western blotting using phospho-
SAPK/JNK (Thr183/Tyr185) antibody and SAPK/JNK
(56G8) rabbit mAb. P38 was analyzed by western blotting
using phospho-p38MAPK (Thr180/Tyr182) antibody and
p38MAPK antibody. Phospho-p44/42 MAPK antibody,
p44/42 MAPK antibody, phospho-SAPK/JNK antibody,
SAPK/JNK rabbit mAb and p38MAPK antibody were
purchased from Santa Cruz biotechnology.
Analysis of intranuclear transfer of IRF5
For analysis of IRF5 transfer into the nucleus, the nuclear
and cytoplasmic fractions were exposed to the primary anti-
body (anti-IRF5 antibody) and the HRP-labeled secondary
antibody (anti-goat IgG-HRP), followed by western blotting.
Anti-IRF5 antibody and anti-gout IgG-HRP were purchased
from Santa Cruz Biotechnology.
Analysis of SOCS1 expression
For analysis of SOCS1 expression, samples were exposed
to the primary antibody (anti-SOCS1 antibody) and the
HRP-labeled secondary antibody (anti-rabbit IgG-HRP),
followed by western blotting. Anti-SOCS1 antibody and
anti-rabbit IgG-HRP were purchased from Santa Cruz
Biotechnology.
Western blot analysis
At the end of the incubation period, the medium was
removed and the cells were immediately lysed and trans-
ferred by sodium dodecyl sulfate/polyacrylamide gel electro-
phoresis; proteins were then blotted to nitrocellulose
membranes using a semidry transfer apparatus (Pharmacia
Biotech, Freiburg, Germany). Blots were blocked for 2 h in
5% (wt/vol) bovine serum albumin containing 20 mmol/L
Tris, pH 7.5, 150 mmol/L NaCl, and 0.1% Tween 20
(TBS-T) and then incubated at 4°C overnight with the first
antibody. Following washing with TBS-T and incubation
with horseradish peroxidase-coupled anti-mouse, anti-goat,
or anti-rabbit immunoglobulin G antibody at room tempera-
ture for 2 h, respectively, the blots were washed extensively
and developed using enhanced chemiluminescent detection
(Amersham Pharmacia Biotech, Uppsala, Sweden). Blots
were exposed to Kodak X-OMAT AR-5 film (Eastman
Kodak Co., Rochester, NY).
Results
In the LPS-stimulated group, the phosphorylation of IkB,
phospho-p44/42 MAPK antibody and p44/42 MAPK
antibody, phospho-SAPK/JNK (Thr183/Tyr185) antibody)
and phospho-p38MAPK (Thr180/Tyr182) antibody and
p38MAPK antibody was suppressed after 6 h of stimulation
as compared to that observed after 1h of stimulation (Figs. 1,
2, 3 and 4), and intranuclear transfer of IFR5 and NF-kB
was noted (Figs. 5 and 6). In the LPZ-treated group, the
phosphorylation of IkB, phospho-p44/42 MAPK antibodyEffects of Lansoprazole on the TLR4 Signal Transduction
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and p44/42, phospho-SAPK/JNK (Thr183/Tyr185) antibody)
and phospho-p38MAPK (Thr180/Tyr182) antibody and
p38MAPK antibody was not suppressed (Figs. 1, 2, 3 and 4),
and intranuclear transfer of IFR5 was not suppressed under
stimulation with LPS (Fig. 6). The induction of SAPK/JNK
(56G8) rabbit mAb was yet presence in all groups (Fig. 3).
And then in the LPZ-treated groups, enhanced intranuclear
transfer of NF-kB and increased expression of SOCS1 were
noted, as compared to the observations in the group stimu-
lated with LPS alone (Fig. 7).
Discussion
The present study was undertaken to examine whether or
not LPZ might suppress phosphorylation of IkB and MAPK
or intranuclear transfer of NF-kB and IRF5 and to evaluate
the effects of LPZ on SOCS1 as a negative feedback gene
involved in the TLR4 signal transduction system under
Fig. 1. The phosphorylation of IkB-α analyzed by western-blotting. An arrow indicates the induction of IkB-α. LPZ and LPS denotes
lansoprazole and lipopolysaccharide, respectively.
Fig. 2. The phosphorylation of ERK (phospho-p44/42 MAPK antibody and p44/42 MAPK antibody) analyzed by western-blotting.
Arrows indicate the induction of phospho-p44/42 MAPK antibody and p44/42 MAPK antibody, respectively.T. Ohara et al.
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stimulation with LPS. In the analysis of the effects of LPZ
on LPS-stimulated TLR4 signal transduction, LPZ did not
suppress either phosphorylation of MAPK (IkB, ERK, JNK
or p38) or IRF5 transfer into the nucleus. NK-kB transfer
into the nucleus, which might possibly lead to exacerbation
of inflammatory reactions, seemed to be stimulated by LPS.
In the LPZ-treated group, increase in the expression of
SOCS1 was observed. Previous studies using various
systems have demonstrated that LPZ exerts anti-inflammatory
activity such as the suppression of cytokine formation.
Taking into consideration the results of the present study and
previous reports, it seems possible that LPZ stimulates the
transfer of NF-kB into the nucleus during LPS-stimulated
TLR4 signal transduction, which, in turn, leads to the induc-
Fig. 3. The phosphorylation of JNK (phospho-SAPK/JNK (Thr183/Tyr185) antibody and SAPK/JNK (56G8) rabbit mAb) analyzed by
western-blotting. Arrows indicate the induction of phospho-SAPK/JNK (Thr183/Tyr185) antibody. The phosphorylation of
SAPK/JNK (56G8) rabbit mAb was obscure.
Fig. 4. The phosphorylation of p38 (phospho-p38MAPK (Thr180/Tyr182) antibody and p38MAPK antibody) analyzed by western-
blotting. An arrow indicates the induction of phospho-p38MAPK (Thr180/Tyr182) antibody and p38MAPK antibody, respec-
tively.Effects of Lansoprazole on the TLR4 Signal Transduction
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tion of SOCS1 expression and anti-inflammatory activity.
Because of limitations related to cell specificity, the results
of this study cannot be reasonably extrapolated to other
cells. For strict demonstration of the anti-inflammatory
activity of LPZ using the test system employed in this study,
it is necessary to measure the cytokines formed in both
the LPZ-treated groups and non LPZ-treated groups.
Furthermore, since cell extracts were used in the present
study, it remains unknown whether the results from this
study might reflect the events in the cell membrane or the
events in the cytoplasm. It has recently been reported that
MyD88, an adaptor molecule for TLRs (TLR2, 4), regulates
the conduction of stimuli through TLRs, working together
with heat shock protein (HSP)-associated molecules, such as
HSP70, HSP90, Grp96 and Grp78 [17–21]. Also for the
testing system employed in this study, it would be desirable
to clarify the involvement of these HSP-associated mole-
cules. In any event, the results of the present study suggest
the possibility that LPZ induces SOCS1 and this regulates
protein phosphorylation during TLR4 signal transduction.
Fig. 5. The result of the transition from cytoplasm to nucleus of NF-kBp65 analyzed by western-blotting. An arrow indicates the
induction of NF-kB.
Fig. 6. The result of the transition from cytoplasm to nucleus of IRF5 analyzed by western-blotting. An arrow indicates the induction
of IRF5.T. Ohara et al.
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Conclusion
These results suggest that LPZ stimulates the expression
of SOCS1 and regulates protein phosphorylation through its
activity on TLR4 signal transduction under LPS stimulation
in the 293hTLR4/MD2-CD14 cells. This is a noteworthy
new finding. We propose to analysis the particular account
of this study using different cell lines or using cell cultures
other techniques.
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